Electronic patient messages to promote colorectal cancer screening: a randomized controlled trial
- PMID: 21149743
- PMCID: PMC3169179
- DOI: 10.1001/archinternmed.2010.467
Electronic patient messages to promote colorectal cancer screening: a randomized controlled trial
Abstract
Background: Colorectal cancer is a leading cause of cancer mortality, yet effective screening tests are often underused. Electronic patient messages and personalized risk assessments delivered via an electronic personal health record could increase screening rates.
Methods: We conducted a randomized controlled trial in 14 ambulatory health centers involving 1103 patients ranging in age from 50 to 75 years with an active electronic personal health record who were overdue for colorectal cancer screening. Patients were randomly assigned to receive a single electronic message highlighting overdue screening status with a link to a Web-based tool to assess their personal risk of colorectal cancer. The outcomes included colorectal cancer screening rates at 1 and 4 months.
Results: Screening rates were higher at 1 month for patients who received electronic messages than for those who did not (8.3% vs 0.2%, P < .001), but this difference was no longer significant at 4 months (15.8% vs 13.1%, P = .18). Of 552 patients randomized to receive the intervention, 296 (54%) viewed the message, and 47 (9%) used the Web-based risk assessment tool. Among 296 intervention patients who viewed the electronic message, risk tool users were more likely than nonusers to request screening examinations (17% vs 4%, P = .04) and to be screened (30% vs 15%, P = .06). One-fifth of patients (19%) using the risk assessment tool were estimated to have an above-average risk for colorectal cancer.
Conclusion: Electronic messages to patients produce an initial increase in colorectal cancer screening rates, but this effect is not sustained over time.
Trial registration: clinicaltrials.gov Identifier: NCT01032746.
Figures
Similar articles
-
Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial.Arch Intern Med. 2009 Feb 23;169(4):364-71. doi: 10.1001/archinternmed.2008.564. Arch Intern Med. 2009. PMID: 19237720 Free PMC article. Clinical Trial.
-
Electronic Health Record Portal Messages and Interactive Voice Response Calls to Improve Rates of Early Season Influenza Vaccination: Randomized Controlled Trial.J Med Internet Res. 2020 Sep 25;22(9):e16373. doi: 10.2196/16373. J Med Internet Res. 2020. PMID: 32975529 Free PMC article. Clinical Trial.
-
Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.JMIR Mhealth Uhealth. 2019 Feb 5;7(2):e11114. doi: 10.2196/11114. JMIR Mhealth Uhealth. 2019. PMID: 30720439 Free PMC article.
-
An electronic family health history tool to identify and manage patients at increased risk for colorectal cancer: protocol for a randomized controlled trial.Trials. 2019 Oct 7;20(1):576. doi: 10.1186/s13063-019-3659-y. Trials. 2019. PMID: 31590688 Free PMC article.
-
Patient outreach to promote colorectal cancer screening among patients with an expired order for colonoscopy: a randomized controlled trial.Arch Intern Med. 2011 Apr 11;171(7):642-6. doi: 10.1001/archinternmed.2010.468. Epub 2010 Dec 13. Arch Intern Med. 2011. PMID: 21149742 Clinical Trial.
Cited by
-
Development of an Electronic Health Record Self-Referral Tool for Lung Cancer Screening: One-Group Posttest Study.JMIR Form Res. 2024 Jun 12;8:e53159. doi: 10.2196/53159. JMIR Form Res. 2024. PMID: 38865702 Free PMC article.
-
Decision aids for people facing health treatment or screening decisions.Cochrane Database Syst Rev. 2024 Jan 29;1(1):CD001431. doi: 10.1002/14651858.CD001431.pub6. Cochrane Database Syst Rev. 2024. PMID: 38284415 Review.
-
Patient Engagement in Patient Portals in Appalachia v. Surrounding U.S. Census Regions: An Analysis of HINTS (Health Information National Trends Survey) Data, 2017-2020.J Appalach Health. 2023 Aug 1;5(2):50-65. doi: 10.13023/jah.0502.05. eCollection 2023. J Appalach Health. 2023. PMID: 38022493 Free PMC article.
-
Colorectal Cancer Screening Among Adults in Zuni Pueblo: Factors Associated with FOBT and Colonoscopy Utilization.J Community Health. 2023 Aug;48(4):565-575. doi: 10.1007/s10900-023-01196-7. Epub 2023 Feb 8. J Community Health. 2023. PMID: 36752868 Free PMC article.
-
Novel Implementation Strategy to Electronically Screen and Signpost Patients to Health Behavior Apps: Mixed Methods Implementation Study (OptiMine Study).JMIR Form Res. 2022 Jul 11;6(7):e34271. doi: 10.2196/34271. JMIR Form Res. 2022. PMID: 35816374 Free PMC article.
References
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249. - PubMed
-
- Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–1371. - PubMed
-
- Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477. - PubMed
-
- Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–1471. - PubMed
-
- Selby JV, Friedman GD, Quesenberry CP, Jr., Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–657. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
